Abstract
Epidemiology is the study of the frequency of disease within the community, and requires analysis and interpretation of distribution patterns of disease in terms of possible causal factors. Proof of causal association between a factor and a disease, is however, seldom provided by an epidemiological study. Thyroid dysfunction can be classified according to the severity of clinical findings, serum hormone levels, the presence or absence of thyroid antibodies, or the biochemical or physiological effect in the target tissues. The problems encountered in epidemiological studies of thyroid disorders are those of definition, e.g., overt hypothyroidism and subclinical hypothyroidism, the selection criteria used, the influence of age, sex, environmental factors, and the different techniques used for the measurement of thyroid function (see also Chapter 9). The most commonly used initial tests in epidemiological surveys are measurements of serum total or free thyroxine (T4) and sensitive (second- generation) thyroid-stimulating hormone (TSH).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text, 7th ed. JB Lippincott-Raven, Philadelphia, 1996, pp. 474–482.
Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in the community: The Whickham Survey. Clin Endocrinol 1977;7:481–493.
Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community—a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995;43:55–69.
Hoffenberg R. Aetiology of hyperthyroidism—part I. Br Med J 1974;3:452–456.
Eggertsen R, Petersen K, Lundberg P-A, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. Br Med J 1988; 297:1586–1591.
Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc 1989; 37:317–322.
Kågedal B, Månson JC, Norr A, Sörbo B, Tegler L. Screening for thyroid disorders in middle-aged women by computer-assisted evaluation of a thyroid hormone panel. Scand J Clin Lab Invest 1981;41: 403–408.
Baldwin DB, Rowett D. Incidence of thyroid disorders in Connecticut. JAMA 1978;239:742–744.
dos Remedios LV, Weber PM, Feldman R, Schurr DA, Tsoi TG. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch Intern Med 1980;140:1045–1049.
Schaaf L, Pohl T, Schmidt R, Vardali I, Teuber J, Schlote-Sauter B, et al. Screening for thyroid disorders in a working population. Clin Invest 1993;71:126–131.
Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol 1993;38:273–281.
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1991;34: 77–83.
Falkenberg M, Kågedal B, Norr A. Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand 1983;214:361–365.
Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990;150:785–787.
Brochmann H, BjФro T, Gaarder PI, Hanson F, Frey HM. Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (NærФy). Acta Endocrinol 1988;117: 7–12.
Campbell AJ, Reinken J, Allan BC. Thyroid disease in the elderly in the community. Age Ageing 1981; 10:47–52.
Sundbeck G, Lundberg P-A, Lindstedt G, Jagenburg R, Eden S. Incidence and prevalence of thyroid disease in elderly women: results from the longitudinal population study of elderly people in Gothenburg, Sweden. Age Ageing 1991;20:291–298.
Kaplan MM, Reed Larsen P, Cranzt FR, Dzau VJ, Rossing TH. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 1982;72:9–16.
Gow SM, Elder A, Caldwell G, Bell G, Seth J, Sweeting VM, et al. An improved approach to thyroid function testing in patients with non-thyroidal illness. Clin Chim Acta 1986;158:49–58.
Small M, Buchanan L, Evans R. Value of screening thyroid function in acute medical admissions to hospital. Clin Endocrinol 1990;32:185–191.
DeGroot LJ, Mayor G. Admission screening by thyroid function tests in an acute general care teaching hospital. Am J Med 1992;93:558–564.
Simons RJ, Simon JM, Demers LM, Santen RJ. Thyroid dysfunction in elderly hospitalized patients. Effect of age and severity of illness. Arch Intern Med 1990;150:1249–1253.
Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PWF, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991; 151:165–168.
Furszyfer J, Kurland LT, McConahey WM, Elveback LR. Graves’ disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc 1970;45:636–644.
Mogensen EF, Green A. The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972–1974. Acta Med Scand 1980;208:183–186.
Haraldsson A, Gudmundsson ST, Larusson G, Sigurdsson G. Thyrotoxicosis in Iceland 1980–1982. An epidemiological survey. Acta Med Scand 1985;217:253–258.
Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves’ thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970–1974. J Intern Med 1990;227:137–141.
Kalk WJ, Kalk J. Incidence and causes of hyperthyroidism in blacks. S Afr Med J 1989;75:114–116.
Barker DJB, Phillips DIW. Current incidence of thyrotoxicosis and past prevalence of goitre in 12 British towns. Lancet 1984;ii:567–570.
Phillips DIW, Barker DJ, Rees Smith B, Didcote S, Morgan D. The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol 1985;23:283–287.
Nystrom E, Bengtsson C, Lindquist 0, Noppa H, Lindstedt G, Lundberg P-A. Thyroid disease and high concentration of serum thyrotrophin in a population sample of women. Acta Med Scand 1981;210: 39–46.
Nystrom E, Bengtsson C, Lindquist 0, Lindberg S, Lindstedt G, Lundberg P-A. Serum triiodothyronine and hyperthyroidism in a population sample of women. Clin Endocrinol 1984;20:31–42.
Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med 1991;78:77–84.
Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PWF, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991;151: 165–168.
Goudie RB, Anderson JR, Gray KG. Complement fixing thyroid antibodies in hospital patients with asymptomatic thyroid lesions. J Pathol Bacteriol 1959;90:389–400.
36. Bastenie PA, Neve P, Bonnyns M, Vanhaelst L, Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. Lancet 1967;i:915–919.
Williams ED, Doniach I. The post mortem incidence of focal thyroiditis. J Pathol Bacteriol 1962; 83:255–264.
Dingle PR, Ferguson A, Horn DB, Tubmen J, Hall R. The incidence of thyroglobulin antibodies and thyroid enlargement in a general practice in North East England. Clin Exp Immunol 1966;1:277–284.
Couchman KG, Wigley RD, Prior IAM. Autoantibodies in the Carterton Population Survey. J Chronic Dis 1970;23:45–53.
Hooper B, Whittingham S, Matthews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp Immunol 1972;12:79–87.
Gordin A, Maatela J, Miettinen A, Helenius T, Lamberg B-A. Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population. Acta Endocrinol 1979;90:33–42.
42. Hawkins BR, Cheah PS, Dawkins RL, Whittingham S, Burger HG, Patel Y, Mackay IR, et al. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980;ii:1057–1059.
Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, et al. Thyroid and other organspecific autoantibodies in healthy centenarians. Lancet 1992;339:1506–1508.
Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386–1388.
Lazarus JH, Burr ML, McGregor AM, Weetman AP, Ludgate M, Woodhead JS, et al. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol 1984;106:199–202.
Prentice LM, Phillips DIW, Sarsero D, Beever K, McLachlan SM, Rees Smith B. Geographical distribution of subclinical autoimmune thyroid disease in Britain: A study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol 1990;123:493–498.
Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE. Prevalence of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies. Clin Chem 1992;38:88–92.
Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996;6:155–160.
Jans son R, Karlsson A, Dahlberg PA. Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto’s thyroiditis. Br Med J 1985;290:11,12.
Takusu N, Yamada T, Takusu M, Komiya I, Nagasawa Y, Asawa T, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513–518.
Lowrey R, Starr P. Chemical evidence of incidence of hypothyroidism. JAMA 1959;171:2045–2048.
52. Gordin A, Heinonen OP, Saarinen P, Lamberg B-A. Serum-thyrotrophin in symptomless autoimmune thyroiditis. Lancet 1972;i:551–554.
Hodkinson HM, Denham MJ Thyroid function tests in the elderly in the community. Age Ageing 1977;6:67–70.
Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid. Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med 1985;79:591–595.
Bahemuka M, Hodkinson HM. Screening for hypothyroidism in elderly inpatients. Br Med J 1975;2: 601–603.
56. Franklyn JA. “Subclinical hypothyroidism”: to treat or not to treat, that is the question. Clin Endocrinol 1995;43:443–444.
57. Toft AD, Irvine WJ, Seth J, Hunter WM, Cameron EHD. Thyroid function in the long-term followup of patients treated with iodine-131 for thyrotoxicosis. Lancet 1975;ii:576–578.
Evered DC, Young ET, Tunbridge WMG, Ormston BJ, Green E, Petersen VB, et al. Thyroid function after subtotal thyroidectomy for hyperthyroidism. Br Med J 1975;1:25–27.
Lundstrom B, Gillquist J The importance of elevated TSH in serum after subtotal thyroidectomy for hyperthyroidism. Acta Chir Scand 1981;147:645–647.
Franklyn JA, Daykin J, Droic Z, Farmer M, Sheppard MC. Long term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol 1991;34:71 76.
Berglund J, Christensen SB, Dymling JF, Hallengren B. The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970–1974. J Intern Med 1991;229:435–442.
Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S, et al. Development of spontaneous hypothyroidism in patients with Graves’ Disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. Metabolism 1989;69:49–53.
Shigemasa C, Mitani Y, Taniguchi S, Adachi T, Ueta Y, Urabe K, et al. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves’ hyperthyroidism. Arch Intern Med 1990;150:1150–1159.
Tunbridge WMG, Brewis M, French JM, Appleton D, Bird T, Clark F, et al. Natural history of autoimmune thyroiditis. Br Med J 1981;282:258–262.
65. Gordin A, and Lamberg B-A. Natural course of symptomless autoimmune thyroiditis. Lancet 1975;ii: 1234–1238.
Gordin A, Lamberg B-A. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis. A long-term follow-up study. Clin Endocrinol 1981;15:537–543.
Geul KW, van Sluisveld ILL, Grobbee DE, Docter R, de Bruyn AM, Hooykaas H, et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol 1993;39:275–280.
Rosenthal KJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 1987;258:209–213.
Hall R. Pregnancy and autoimmune endocrine disease. Balliere’s Clin Endocrinol Metab 1995;9: 137–155.
Gerstein HC. How common is post-partum thyroiditis? A methodologic overview of the literature. Arch Intern Med 1990;150:1397–1399.
Harris B, Othman S, Davies JA, Weppner GJ, Richards CJ, Newcombe RG, et al. Association between post-partum thyroid dysfunction and thyroid antibodies and depression. Br Med J 1992;305:152–156.
Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up and HLA association in patients with post-partum hypothyroidism. J Clin Endocrinol Metab 1988;66:480–484.
Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCulloch B, et al. The clinical spectrum of postpartum thyroid disease. Q J Med 1996;89:429–435.
Othman S, Phillips DIW, Parkes AB, Richards CJ, Harris B, Fung H, et al. A long term follow-up of postpartum thyroiditis. Clin Endocrinol 1990;32:559–564.
Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto’s thyroiditis. Lancet 1990;336:1084–1086.
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Assessment of a screening process to detect patients aged 60 years and over at high risk of hypothyroidism. Br J Gen Pract 1991;41:414–416.
Cooper DS, Halpern R, Wood LC, Levin AA, Ridgeway ED. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984;101:18–24.
Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Pucci CA, Luisi M, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effects of L-thyroxine treatment. Clin Invest 1993;71: 367–371.
Bell GM, Todd WTA, Forfar JC, Martyn C, Wathen CG, Gow S, et al. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol 1985;22:83–89.
Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol 1988;29:63–76.
Franklyn JA, Daykin J, Betteridge J, Hughes E.A, Holder R, Jones SR, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol 1993;38:453–459.
Bastenie PA. Hypothyroidism and coronary heart disease. Acta Cardiol 1982;37:365–373.
Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol 1995 ;43:445–449.
Tanis BC, Westendorp RGJ, Smelt AHM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a re-analysis of intervention studies. Clin Endocrinol 1996; 44:643–649.
Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285–292.
Gammage M, Franklyn J. Hypothyroidism, thyroxine treatment and the heart. Heart 1997;77:189–190.
Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to Lthyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:631–642.
Tenerz A, Forberg R, Jansson R. ls a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 1990;228:229–233.
Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249–1252.
Foldes J, Tarján G, Szathmari M, Varga F, Krasznai I, Horvath Cs. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis. Clin Endocrinol 1993;39:521–527.
Glueck CJ, Lang J, Tracy T, Speirs J. The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinaemia. Clin Chim Acta 1991;201:113–122.
O’Kane MJ, Neely RDG, Trimble ER, Nicholls DP. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem 1991;28:509–511.
Vanderpump MPJ, Tunbridge WMG. The effects of drugs on endocrine function. Clin Endocrinol 1993;39:389–397.
Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Med 1996;12:622–627.
Giani C, Fierabracci P, Bonacci R, Giglotti A, Campani D, De Negri F, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996;81:990–994.
Oomen HAPC, Schipperijn AMJ, Drexhage HA. The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests. Clin Endocrinol 1996;45:215–223.
Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry 1993;54:47–54.
White AJ, Barraclough B. Thyroid disease and mental illness; a study of thyroid disease in psychiatric admissions. J Pychomatic Res 1988;32:99–106.
Vanderpump MPJ, Ahlquist JAO, Franklyn JA, Clayton RN. Development of consensus for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. Br Med J 1996;313:539–544.
Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A. Long-term prospective study of post-partum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994;79:10–16.
Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotrophin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab 1990; 71:764–769.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vanderpump, M.P.J., Michael, W., Tunbridge, G. (1999). The Epidemiology of Autoimmune Thyroid Disease. In: Volpé, R. (eds) Autoimmune Endocrinopathies. Contemporary Endocrinology, vol 15. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-704-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-704-8_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4572-6
Online ISBN: 978-1-59259-704-8
eBook Packages: Springer Book Archive